These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 34848674

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients.
    Lee H, Han E, Choi AR, Ban TH, Chung BH, Yang CW, Choi YJ, Oh EJ.
    PLoS One; 2018; 13(11):e0207434. PubMed ID: 30427941
    [Abstract] [Full Text] [Related]

  • 3. Relationship among C1q-fixing de novo donor specific antibodies, C4d deposition and renal outcome in transplant glomerulopathy.
    Messina M, Ariaudo C, Praticò Barbato L, Beltramo S, Mazzucco G, Amoroso A, Ranghino A, Cantaluppi V, Fop F, Segoloni GP, Biancone L.
    Transpl Immunol; 2015 Sep; 33(1):7-12. PubMed ID: 26160049
    [Abstract] [Full Text] [Related]

  • 4. Acquisition of C3d-Binding Activity by De Novo Donor-Specific HLA Antibodies Correlates With Graft Loss in Nonsensitized Pediatric Kidney Recipients.
    Comoli P, Cioni M, Tagliamacco A, Quartuccio G, Innocente A, Fontana I, Trivelli A, Magnasco A, Nocco A, Klersy C, Rubert L, Ramondetta M, Zecca M, Garibotto G, Ghiggeri GM, Cardillo M, Nocera A, Ginevri F.
    Am J Transplant; 2016 Jul; 16(7):2106-16. PubMed ID: 26725780
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of C1q Status and Titer of De Novo Donor-Specific Antibodies as Predictors of Allograft Survival.
    Wiebe C, Gareau AJ, Pochinco D, Gibson IW, Ho J, Birk PE, Blydt-Hansen T, Karpinski M, Goldberg A, Storsley L, Rush DN, Nickerson PW.
    Am J Transplant; 2017 Mar; 17(3):703-711. PubMed ID: 27539748
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection.
    Yell M, Muth BL, Kaufman DB, Djamali A, Ellis TM.
    Transplantation; 2015 Jun; 99(6):1151-5. PubMed ID: 25839705
    [Abstract] [Full Text] [Related]

  • 10. C1q Donor-Specific Antibody Associates with Post-transplant Biopsy Findings in Highly- Sensitized Kidney Transplant Recipients.
    Kuppachi S, Holanda D, Gallegos S, Field EH.
    Clin Transpl; 2016 Jun; 32():127-134. PubMed ID: 28564530
    [Abstract] [Full Text] [Related]

  • 11. Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.
    Sicard A, Ducreux S, Rabeyrin M, Couzi L, McGregor B, Badet L, Scoazec JY, Bachelet T, Lepreux S, Visentin J, Merville P, Fremeaux-Bacchi V, Morelon E, Taupin JL, Dubois V, Thaunat O.
    J Am Soc Nephrol; 2015 Feb; 26(2):457-67. PubMed ID: 25125383
    [Abstract] [Full Text] [Related]

  • 12. Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies.
    Kim JJ, Shaw O, Martin C, Michaelides G, Balasubramaniam R, Sebire NJ, Mamode N, Dorling A, Vaughan R, Marks SD.
    Pediatr Nephrol; 2018 Jan; 33(1):167-174. PubMed ID: 28918487
    [Abstract] [Full Text] [Related]

  • 13. The disappointing contribution of anti-human leukocyte antigen donor-specific antibodies characteristics for predicting allograft loss.
    Courant M, Visentin J, Linares G, Dubois V, Lepreux S, Guidicelli G, Thaunat O, Merville P, Couzi L, Taupin JL.
    Nephrol Dial Transplant; 2018 Oct 01; 33(10):1853-1863. PubMed ID: 29672702
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
    Olszowska-Zaremba N, Gozdowska J, Zagożdżon R.
    Transpl Immunol; 2022 Oct 01; 74():101672. PubMed ID: 35868613
    [Abstract] [Full Text] [Related]

  • 15. Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes?
    Cicciarelli JC, Lemp NA, Chang Y, Koss M, Hacke K, Kasahara N, Burns KM, Min DI, Naraghi R, Shah T.
    J Immunol Res; 2017 Oct 01; 2017():1652931. PubMed ID: 28182088
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relationship between Mean Fluorescence Intensity and C1q/C3d-fixing capacities of anti-HLA antibodies.
    Claisse G, Absi L, Cognasse F, Alamartine E, Mariat C, Maillard N.
    Hum Immunol; 2017 Apr 01; 78(4):336-341. PubMed ID: 28189573
    [Abstract] [Full Text] [Related]

  • 18. Clinical Outcome of Kidney Transplant Recipients with C1q-Binding De Novo Donor Specific Antibodies: A Single-Center Experience.
    Marinaki S, Vittoraki A, Tsiakas S, Kofotolios I, Darema M, Ioannou S, Vallianou K, Boletis J.
    J Clin Med; 2023 Jul 04; 12(13):. PubMed ID: 37445510
    [Abstract] [Full Text] [Related]

  • 19. Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective study.
    Cioni M, Nocera A, Tagliamacco A, Basso S, Innocente A, Fontana I, Magnasco A, Trivelli A, Klersy C, Gurrado A, Ramondetta M, Boghen S, Catenacci L, Verrina E, Garibotto G, Ghiggeri GM, Cardillo M, Ginevri F, Comoli P.
    Transpl Int; 2019 Jan 04; 32(1):38-48. PubMed ID: 30076765
    [Abstract] [Full Text] [Related]

  • 20. De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients.
    Cioni M, Nocera A, Innocente A, Tagliamacco A, Trivelli A, Basso S, Quartuccio G, Fontana I, Magnasco A, Drago F, Gurrado A, Guido I, Compagno F, Garibotto G, Klersy C, Verrina E, Ghiggeri GM, Cardillo M, Comoli P, Ginevri F.
    J Immunol Res; 2017 Jan 04; 2017():1747030. PubMed ID: 28367453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.